Literature DB >> 23164800

Edelfosine and perifosine disrupt hepatic mitochondrial oxidative phosphorylation and induce the permeability transition.

Ana Burgeiro1, Cláudia V Pereira, Filipa S Carvalho, Gonçalo C Pereira, Faustino Mollinedo, Paulo J Oliveira.   

Abstract

Edelfosine and perifosine are alkylphospholipids that have been intensively studied as potential antitumor agents. Apoptotic cell death caused by these two compounds is mediated, at least in part, through mitochondria. Additionally, previous works demonstrated that edelfosine induces changes in mitochondrial membrane permeability that are somehow reduced by using cyclosporin A. Therefore, the objective of the present study was not only to confirm mitochondrial permeability transition but also identify direct effects of both ether lipids on mitochondrial hepatic fractions, namely on mitochondrial oxidative phosphorylation and generation of hydrogen peroxide (H(2)O(2)) through the respiratory chain. Results show that edelfosine and perifosine inhibit mitochondrial respiration and decrease transmembrane electric potential. However, despite these effects, edelfosine and perifosine were still able to induce mitochondrial permeability transition in non-energized mitochondria. Interestingly, edelfosine decreased H(2)O(2) production through the respiratory chain. In conclusion, the present work demonstrates previously unknown alterations of mitochondrial physiology directly induced by edelfosine and perifosine. The study is relevant in the understanding of mitochondrial-target effects of both compounds, as well as to acknowledge possible toxic responses in non-tumor organs. 2012 Elsevier B.V. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164800     DOI: 10.1016/j.mito.2012.11.003

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  3 in total

Review 1.  Lipid analogues as potential drugs for the regulation of mitochondrial cell death.

Authors:  Michael Murray; Herryawan Ryadi Eziwar Dyari; Sarah E Allison; Tristan Rawling
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines.

Authors:  B C Valdez; A R Zander; G Song; D Murray; Y Nieto; Y Li; R E Champlin; B S Andersson
Journal:  Blood Cancer J       Date:  2014-01-10       Impact factor: 11.037

Review 3.  Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  Pharmaceutics       Date:  2021-05-20       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.